Article
Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms.
The Kurume medical journal - 1 Jan 2014
Takata Yuka, Seki Ritsuko, Kanajii Taisuke, Nohara Masayuki, Koteda Satoko, Kawaguchi Kuniki, Nomura Kei, Nakamura Takayuki, Morishige Satoshi, Oku Eijirou, Osaki Koichi, Hashiguchi Emichitoshi, Mouri Fumihiko, Yoshimoto Koji, Nagafuji Koji, Okamura Takashi
Abstract excerpt
Thrombotic complications are a major cause of death in patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), which are closely associated with the JAK2 V617F activating mutation. However, whether the presence of the JAK2 V617F mutation affects thrombotic risk is curr...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.